Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...
Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...
Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
NBC News on MSN14d
FDA approves new type of nonopioid painkiller for acute painVertex’s drug works in a completely different way ... Lidocaine, a local anesthetic, works by blocking all sodium channels in the area it’s applied to — for example, the gums during dental work. A ...
The cost-efficient model dubbed Gemini 2.0 Flash-Lite comes as a successor to the Gemini 1.5 Flash while sticking to the same ...
Announced in December, 2.0 Flash Thinking rivals OpenAI's o1 and o3-mini reasoning models in that it's capable of working ...
Now comes the interesting thing for business and tax leaders, as this year, the impacts of these massive political ...
Vertex Pharmaceuticals (NASDAQ ... One is the company's efforts to make the drug affordable, for example, offering a savings program that allows eligible patients to pay as little as $30 dollars ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results